Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Says Most SQL*LIMS Employees Expected to Transfer to LabVantage Following Sale of Business

Premium

A Life Technologies spokesperson said today that "most" of the 75 employees in its SQL*LIMS business are expected to transfer to LabVantage as part of the firm's sale of that business to the LIMS vendor.

The sale is expected to close in the third quarter of 2009. Financial terms of the agreement were not provided.

Life Technologies said it "does not expect this transaction to have a material affect on its financials in fiscal year 2009." The company does not break out revenues for its product lines.

"While the LIMS business is an important asset for a segment of our customers, it was not a perfect fit with our strategic direction," Mark Stevenson, Life Technologies' president and COO, said in a statement. "This agreement will allow us to better focus on our strengths, while ensuring continued access to a key solution in the laboratory workflow."

Under the terms of the agreement, LabVantage will continue to support the SQL*LIMS product and "customers will receive the same level of support to which they have been accustomed," Life Tech said in a statement.

SQL*LIMS, a product line within Life Technologies' Applied Biosystems group, is a multi-tiered enterprise laboratory information management system used for tracking raw materials and samples, sample analysis, data collection, and transfer of this information to other systems.

According to the ABI Website, SQL*LIMS is currently used by more than 30,000 researchers and installed in more than 1,000 laboratories worldwide.

LabVantage, founded in 1981 and based in Bridgewater, NJ, markets the Sapphire line of LIMS products and has more than 200 employees.

The firm is active in a number of vertical industries, including the life sciences. On its website, the firm lists 57 biotech and pharma customers for Sapphire LIMS, including Abbott Laboratories, Bristol-Myers Squibb, Johnson & Johnson, Novartis, and "other global pharmaceutical giants." It also lists Applied Biosystems sister company Invitrogen among its Sapphire customers.

"We are confident that our customers will benefit from the increased focus of a software solutions company," said Pat Pijanowski, general manager of the SQL*LIMS business unit for Life Tech.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.